Haohai Biological shareholder fined by CSRC for insider trading

Shanghai Haohai Biological Technology Co., Ltd. announced on December 23, 2025, that Mr. Jiang Wei, one of its controlling shareholders and de facto controllers, has been penalized by the China Securities Regulatory Commission (CSRC). The Administrative Penalty Decision follows a previous Administrative Penalty Notice regarding matters unrelated to the company.

The CSRC has decided to confiscate illegal gains of RMB4,709,741.41 from Mr. Jiang Wei and impose a fine of RMB14,629,224.23. These penalties are for insider trading and recommending securities trading to others.

Shanghai Haohai Biological Technology stated that the matters involved are unrelated to the company and Mr. Jiang Wei is not involved in its day-to-day management or operations. The company assures that the penalty will not materially impact its daily operations, business, or financial position, with production and operation activities proceeding in an orderly manner.